ARTICLEhttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/10/article-pxxii.xmlNCCN News2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/10/article-pxxii.pdf2026-04-18NCCN Newshttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/10/article-p1161.xmlOne Size Fits All? Really?2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/10/article-p1161.pdf2026-04-18One Size Fits All? Really?https://harbor.dev.pubfactory.com/view/journals/jnccn/16/10/article-pxxxiii.xmlOncology Research Program2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/10/article-pxxxiii.pdf2026-04-18Oncology Research Programhttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/10/article-p1171.xmlNCCN Guidelines Insights: Small Cell Lung Cancer, Version 2.20182026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/10/article-p1171.pdf2026-04-18NCCN Guidelines Insights: Small Cell Lung Cancer, Version 2.2018https://harbor.dev.pubfactory.com/view/journals/jnccn/16/10/article-p1166.xmlFirst-Line Treatment of Widely Metastatic BRAF-Mutated Salivary Duct Carcinoma With Combined BRAF and MEK Inhibition2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/10/article-p1166.pdf2026-04-18First-Line Treatment of Widely Metastatic BRAF-Mutated Salivary Duct Carcinoma With Combined BRAF and MEK Inhibitionhttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/10/article-p1163.xmlShades of Survivorship2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/10/article-p1163.pdf2026-04-18Shades of Survivorshiphttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/10/article-p1209.xmlTumor Board Conferences for Multidisciplinary Skin Cancer Management: A Survey of US Cancer Centers2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/10/article-p1209.pdf2026-04-18Tumor Board Conferences for Multidisciplinary Skin Cancer Management: A Survey of US Cancer Centershttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/10/article-p1183.xmlA Routine Laboratory Data–Based Model for Predicting Recurrence After Curative Resection of Stage II Colorectal Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/10/article-p1183.pdf2026-04-18A Routine Laboratory Data–Based Model for Predicting Recurrence After Curative Resection of Stage II Colorectal Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/10/article-p1201.xmlA Study of Novel Febrile Neutropenia Risk Factors Related to Bone Marrow or Immune Suppression, Barrier Function, and Bacterial Flora2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/10/article-p1201.pdf2026-04-18A Study of Novel Febrile Neutropenia Risk Factors Related to Bone Marrow or Immune Suppression, Barrier Function, and Bacterial Florahttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/10/article-p1193.xmlSystemic Therapy for Combined Hepatocellular-Cholangiocarcinoma: A Single-Institution Experience2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/10/article-p1193.pdf2026-04-18Systemic Therapy for Combined Hepatocellular-Cholangiocarcinoma: A Single-Institution Experiencehttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/10/article-p1216.xmlSurvivorship, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/10/article-p1216.pdf2026-04-18Survivorship, Version 2.2018, NCCN Clinical Practice Guidelines in Oncologyhttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/10/article-p1259.xmlImmune Checkpoint Inhibitor Therapy in Breast Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/10/article-p1259.pdf2026-04-18Immune Checkpoint Inhibitor Therapy in Breast Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/10/article-p1251.xmlPreventive Health in Cancer Survivors: What Should We Be Recommending?2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/10/article-p1251.pdf2026-04-18Preventive Health in Cancer Survivors: What Should We Be Recommending?https://harbor.dev.pubfactory.com/view/journals/jnccn/16/10/article-p1269.xmlToward a Personalized Approach in the Treatment of Salivary Ductal Carcinoma2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/10/article-p1269.pdf2026-04-18Toward a Personalized Approach in the Treatment of Salivary Ductal Carcinoma